期刊文献+

布氏菌病双价DNA疫苗免疫保护效果的研究 被引量:2

Construction of Bivalent DNA Vaccine and Evaluation of Its Immunoprotection Efficacy
下载PDF
导出
摘要 【目的】构建布氏杆菌pcDNA3.1(+)-L7/L12-BCSP31双价DNA疫苗,观察其免疫保护效果。【方法】分别克隆L7/L12、BCSP31基因,构建pcDNA3.1(+)-L7/L12-BCSP31双价DNA疫苗。转染COS-7细胞,免疫细胞化学检测目的蛋白的表达。DNA疫苗免疫Balb/c小鼠,观察体液免疫和细胞免疫效果。布氏杆菌强毒株腹腔攻毒,观察双价DNA疫苗的免疫保护效果。【结果】构建的pcDNA3.1(+)-L7/L12-BCSP31双价DNA疫苗在COS-7细胞有目的蛋白的表达。双价DNA疫苗免疫小鼠,ELISA检测双价DNA疫苗产生了高水平的特异性IgG抗体,且抗体亚型以IgG2a为主。FCM检测双价DNA疫苗的CD4+/CD8+比值明显下降。ELISPOT检测到疫苗免疫后小鼠分泌IFN-γ的T细胞增多。攻毒实验证明双价DNA疫苗能够产生有效的保护效果;部分数据及攻毒结果表明双价DNA疫苗的效果优于单价。【结论】研制的pcDNA3.1(+)-L7/L12-BCSP31双价DNA疫苗免疫Balb/c小鼠能产生有效的免疫保护效果,且双价DNA疫苗效果优于单价。 [Objective] To Construct bivalent DNA vaccine encoding L7/L12,BCSP31 and to evaluate its immunogenicity and protective efficacy. [Methods]Brucella abortus L7/L12 ( ribosome protein ) and BCSP31 ( outer membrane lipoprotein ) gene were cloned into the eukaryotic expressing plasmid pcDNA3. 1 ( + ) to get the recombinant plasmid infection in the spleens of vaccinated mice challenged with B. abortus A544. [Results] The bivalent DNA vaccine could be expressed in COS-7 cells. The typical T-helper 1-dominated immune response was determined by immunoglobulin G isotype analysis, FCM and ELISPOT. The high titer specific an- tibody against L7/L12-BCSP3, protein was detected by ELISA. Immunization with pcDNA3. 1 ( + ) L7/L12- BCSP31 could reduce the bacterial burden relative to those in the control group. Some data showed that the bivalent DNA vaccine was better than the monovalent DNA vaccine. [Conclusion]pcDNA3. 1 ( + )-L7/L12-BC SP31 is effective for the production of cell-mediated responses in mice and a basis for the future studies of vaccination against brucellosis. The combination of the two gene is better than the only one which we describe be fore . The present work may be useful to the development of Brucella DNA vaccine.
出处 《医学临床研究》 CAS 2008年第12期2113-2117,共5页 Journal of Clinical Research
基金 国家自然科学基金资助项目(30170853)
关键词 布氏杆茵病/药物疗法 疫苗 DNA/免疫学 brucellosis/DT vaccines,DNA/IM
  • 相关文献

参考文献8

  • 1Ariza J. Brucellosis[J]. Curr Opin Infect Immun , 1996,9: 126-131.
  • 2Tuteja R. DNA vaccines: a ray of hope[J]. Crit Rev Biochem Mol Biol ,1999;34(1):1-24.
  • 3Oliveira SC and Splitter GA. Immunization of mice with recombinant 1.7/L12 ribosomal protein confers protection against Brucella abortus infection[J]. Vaccine , 1996,14 : 959-962.
  • 4Bricker BJ, Tabatabai LB, Deyoe BL, et al . Conservation of antigenicity in a 31 KDa Brucella protein[J]. Vet Microbiol , 1998,18:315-325.
  • 5Leitner WW, Ying H, Rertilo NP. DNA and Rna based vaccines : principles, progress and prospects[J ]. Vaccines, 2000,18 (9/10) :765-777.
  • 6Corbel MJ. Brucellosis: an overview Emerg[J]. Infect Dis , 1997,3:213-221.
  • 7Zhan Y, Yang J. Cheers C. Cytokines response of T-cell subsets from Brucella abortus infected mice to soluble Brucella proteins[J]. Infect Immun ,1993. 61:2841-2847.
  • 8Soto M J, Zorzano A, Nucleotide sequence and characterization of Rhizobium meliloti nodulation competitiveness genes nfe[J], J Mol Biol ,1993,20,229(2) : 570-600.

同被引文献29

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部